Compounded vs Brand-Name GLP-1: How to Read the Trade-Off

Nearly every provider in our ranking sells one of two things: the brand-name drug — Wegovy or Zepbound, straight from the manufacturer — or a compounded version of the same active molecule, mixed by a pharmacy. They are not the same product, and the difference drives most of the price gap you see across the field. Here is how to read it.

What "brand-name" means

Wegovy is semaglutide 2.4 mg, approved by the FDA for chronic weight management in adults who meet the label's BMI criteria³. Zepbound is tirzepatide, approved on the same footing⁴. "FDA-approved" is a specific claim: the agency has reviewed the manufacturer's own clinical data and manufacturing process and cleared the exact product for sale. The efficacy figures the whole category advertises come from trials of these branded molecules — roughly 15% mean weight loss for semaglutide¹ and up to about 21% for tirzepatide².

What "compounded" means

A compounded GLP-1 is the same active ingredient prepared by a pharmacy rather than the drug's manufacturer. Critically, compounded drugs are **not** FDA-approved — the FDA does not review them for safety, effectiveness, or quality before they reach patients⁵. Compounding is legal and long-established, but it operates under a different regulatory frame: 503A pharmacies compound against individual prescriptions, while 503B outsourcing facilities register with the FDA and follow federal manufacturing standards⁶. We unpack that distinction, and how to vet a compounder, in is compounded GLP-1 legit and safe.

Why the price gap exists

The headline reason readers choose compounded is cost. Brand-name GLP-1 carries a manufacturer's list price; compounded versions typically undercut it by a wide margin. That gap is not a trick — it reflects the difference between a patented, FDA-reviewed product and a pharmacy-prepared one. What the gap does not tell you is anything about relative safety in your specific case, which is why the Desk never scores a provider up for being cheap alone.

How to choose between them

Reach for **brand-name** if:

- You want the exact product studied in the pivotal trials and reviewed by the FDA. - You have insurance coverage that narrows the price gap. - You prefer the manufacturer's pre-filled pen and standardized dosing.

Reach for **compounded** if:

- Out-of-pocket cost is the binding constraint and brand pricing is out of reach. - You have vetted the pharmacy — a named, LegitScript-verified operator, ideally a 503B facility. - You are comfortable with a product the FDA has not individually reviewed.

Most of our ranking is compounded-only, but a meaningful minority offer brand access — Ondra Health and Vaylen among them. If brand capability is your filter, start there and compare against the top-scored CoreAge Rx using our alternatives view.

The Desk's read

Neither route is universally "better." Brand-name buys you FDA review and trial-grade certainty; compounded buys you access at a price many patients can actually sustain. The wrong move is choosing compounded blind — from an anonymous pharmacy, on price alone. If you have decided compounded is the route, the Desk's compounded semaglutide ranking prints what our record does and does not confirm about the product behind every price, and the tirzepatide ranking does the same for the other molecule. It also helps to know what a complete compounded price table looks like before you accept a single starting-at figure from anyone: a one-, three- and six-month table with the month-to-month column labeled as such is the shape you want, and it is rarer than it should be. Vet the operator first, decide which molecule you want in our semaglutide vs tirzepatide guide, then use the full comparison desk to line up your finalists. The trial evidence and labeling behind each of those choices is collected in our research library.